genOway Société anonyme

Paris Stock Exchange ALGEN.PA

genOway Société anonyme Gross Profit Margin for the year ending December 31, 2023: 93.80%

genOway Société anonyme Gross Profit Margin is 93.80% for the year ending December 31, 2023, a 1,320.96% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.
  • genOway Société anonyme Gross Profit Margin for the year ending December 31, 2022 was -7.68%, a 71.25% change year over year.
  • genOway Société anonyme Gross Profit Margin for the year ending December 31, 2021 was -26.72%, a 0.54% change year over year.
  • genOway Société anonyme Gross Profit Margin for the year ending December 31, 2020 was -26.87%, a -147.02% change year over year.
  • genOway Société anonyme Gross Profit Margin for the year ending December 31, 2019 was 57.14%, a -0.77% change year over year.
Key data
Date Gross Profit Margin Operating Income Margin EBT Margin Net Income Margin
Market news
Loading...
Paris Stock Exchange: ALGEN.PA

genOway Société anonyme

CEO Dr. Alexandre Fraichard
IPO Date May 7, 2007
Location France
Headquarters Technopark 2
Employees 124
Sector Health Care
Industries
Description

genOway Société anonyme, a biotechnology company, develops, manufactures, commercializes, and sells of custom genetically modified mouse, rat, and cell line models worldwide. It produces customized mouse models, such as knockout (KO) and knockin (KI) mouse models; customized rat models, including constitutive and conditional KO, point mutation KI, and quick KI rat models; and customized cell lines, such as constitutive KO, point mutation KI, reporter KI, quick KI, and KI cell lines. The company also offers humanized immune checkpoint mouse models; immunodeficient and reconstituted mouse and rat strains models; humanized immune target models; other mouse and rat catalog models; and immune checkpoint catalog cell lines. It serves pharmaceutical and life science companies, and academic institutes. The company was founded in 1999 and is headquartered in Lyon, France.

Similar companies

ALBIO.PA

Biosynex SA

USD 2.27

11.78%

ALERS.PA

Eurobio Scientific Société anonyme

USD 26.07

0.60%

StockViz Staff

January 15, 2025

Any question? Send us an email